Accordingly, ATR knockdown may serve as an effective treatment strategy for chemotherapy-resistant, EBV-positive NPC.342 Upregulation of NOTCH ligands (JAG1 or DLL4) and effector (HEY1) in the majority of EBV-positive tumor lines and primary tumors has been observed. This evidence concerns the gene ATR and nasopharyngeal carcinoma.